Page last updated: 2024-10-26

famotidine and Hepatitis

famotidine has been researched along with Hepatitis in 2 studies

Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

Hepatitis: INFLAMMATION of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Famotidine clearance was reduced only in patients with decompensated cirrhosis, probably because of concomitant renal impairment."5.28Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer. ( Ohnishi, K, 1990)
"The pharmacokinetics of famotidine were studied after the administration of a single intravenous dose of 20-mg to seven normal volunteers, six patients with chronic hepatitis, 14 patients with compensated cirrhosis, and seven patients with decompensated cirrhosis."3.68Pharmacokinetics of famotidine after intravenous administration in liver disease. ( Ohnishi, K, 1991)
"Famotidine clearance was reduced only in patients with decompensated cirrhosis, probably because of concomitant renal impairment."1.28Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer. ( Ohnishi, K, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohnishi, K2

Other Studies

2 other studies available for famotidine and Hepatitis

ArticleYear
Pharmacokinetics of famotidine after intravenous administration in liver disease.
    The American journal of gastroenterology, 1991, Volume: 86, Issue:1

    Topics: Adult; Aged; Chronic Disease; Famotidine; Female; Half-Life; Hepatitis; Humans; Infusions, Intraveno

1991
Effects of hepatic disease on the pharmacokinetics of famotidine and effects of famotidine on hepatic hemodynamics and peptic ulcer.
    Hepato-gastroenterology, 1990, Volume: 37 Suppl 1

    Topics: Adult; Chronic Disease; Famotidine; Female; Hepatitis; Humans; Liver Circulation; Liver Cirrhosis; L

1990